Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Julian had spent twenty years building a career that demanded precision. As a senior litigation partner, a foggy morning or a missed detail wasn't just an inconvenience — it could derail a case worth millions. His colleagues knew him as sharp, relentless, methodical. What they didn't know was that for the last decade, he had been operating in a state he privately called "functional exhaustion."
He wasn't falling apart. He was just never fully there.
Julian had been prescribed antidepressants for years. SSRIs, SNRIs, combinations his psychiatrist adjusted every few months. Each one did something — enough to keep him out of the hospital, enough to get him through depositions and trial prep — but none of them restored what he remembered having before. The clarity. The ability to think three moves ahead without effort. The feeling of actually wanting to be in the room.
His PHQ-9 scores hovered in the moderate range. His doctors called it a "partial response." Julian called it surviving.
He tried therapy. He tried exercise routines, meditation apps, supplements his friends recommended. Some helped around the edges. Nothing broke through.
When his psychiatrist mentioned ketamine therapy, Julian was skeptical. He'd read the headlines — celebrities using it recreationally, clinics charging thousands for IV drips. It didn't sound like medicine. It sounded like hype.
But he was running out of options.
Julian started a managed oral ketamine protocol through Isha Health. The first session was strange — he described it later as "being aware of my thoughts without being trapped in them." Not euphoric. Not an escape. More like his mind had been given permission to reorganize.
By the second week, something had shifted. He woke up one morning and realized he hadn't dreaded opening his laptop. It was a small thing, but for Julian, it was seismic. He hadn't felt that absence of dread in years.
By the end of his initial treatment phase, his PHQ-9 score dropped to a 1 — near-total remission. For the first time in a decade, the weight was gone.
Julian went back to the courtroom with his full cognitive toolkit restored. He prepared briefs with the precision he remembered from his thirties. He engaged with colleagues instead of performing engagement. He slept through the night.
On paper, he was a clinical success story. A textbook case of ketamine working exactly as the research suggested it could.
What happened next is the part that doesn't make it into the headlines.
As Julian's treatment moved into maintenance — sessions spaced further apart to sustain his remission — a subtle shift began. His PHQ-9 still said 1. His performance at work was strong. But Julian noticed something his score didn't capture.
He started describing a feeling of being "wobbly."
It wasn't depression. Not yet. It was more like the ground beneath his stability had become less solid. A chunk of the evening started to feel heavy again. Not the full weight — just a shadow of it. He told his clinician he was "scared to stop" treatment because he vividly remembered a previous year when he'd tried to taper off other medications and, in his words, "the bottom fell out."
His doctor listened. Julian's numbers were perfect. But his words were telling a different story.
Six weeks after Julian first used the word "wobbly," his PHQ-9 caught up to what his intuition had been signaling all along.
In a single reporting cycle, his score surged from 1 to 20. Remission to severe depression. The bottom had fallen out again.
It was the same devastating freefall he'd experienced before — the difference was that this time, his clinical team had been watching for it. They had documented the early warning signs in his own words, weeks before any standardized measure could detect the change.
His maintenance interval was shortened. His protocol was adjusted. Within three weeks, Julian was stabilizing again.
Julian's experience illustrates something that anyone considering ketamine therapy — or any treatment for depression — needs to understand: remission is not a destination. It is a state that requires active maintenance.
Three things stand out from his case:
The gap between feeling and scoring. Julian felt his stability eroding 45 days before his PHQ-9 reflected it. Standardized assessments are essential tools, but they are lagging indicators. The patient's own narrative — their words, their metaphors, their gut feelings — can be a leading indicator that something is shifting.
Maintenance is not optional. For people with treatment-resistant depression, particularly those in high-performance roles where cognitive function is career-critical, maintenance sessions aren't just "boosters." They are infrastructure. Extending intervals too aggressively can allow neuroplastic gains to recede before anyone notices.
Adaptive care matters. When Julian said he felt wobbly, his care team didn't wait for the numbers to confirm it. They listened, documented, and were ready to act. This is the difference between reactive psychiatry — waiting for a crisis — and proactive care that sustains the gains.
Julian continues his ketamine protocol at a maintenance interval that his clinical team and he arrived at together — shorter than what the textbook might suggest, but tuned to what his brain actually needs. His PHQ-9 has been stable for months. More importantly, he reports feeling stable — not just scoring stable.
He still practices law. He still works long hours. But he no longer describes himself as "functionally exhausted." He describes himself as someone who takes his brain chemistry as seriously as he takes his caseload.
"I used to think maintenance meant I wasn't really better," he said recently. "Now I think of it like keeping the lights on. You don't wait for the power to go out to pay the electric bill."
Ketamine therapy can produce rapid, sometimes dramatic improvements in treatment-resistant depression. But the initial breakthrough is only the beginning. Sustaining remission requires ongoing clinical attention, honest patient-clinician communication, and a willingness to adjust the protocol when subjective experience diverges from standardized scores.
Julian's story is not unusual. It is, in many ways, the typical journey for patients who respond well to ketamine: a transformative beginning, followed by the quieter, harder work of making it last.
This case study is derived from de-identified clinical records. "Julian" is a pseudonym. Specific clinical details, including PHQ-9 scores and verbatim patient descriptors, are drawn from longitudinal treatment documentation.
If you're considering ketamine therapy, Isha Health offers physician-led at-home treatment via telemedicine in California, New York, Texas, Florida, Colorado, Arizona, Georgia, Oregon, and Washington. No in-person visit required.
Stay informed on ketamine therapy
Research updates, clinical insights, and mental health resources — delivered to your inbox.
